Zhongsheng Pharmaceutical (002317.SZ) obtained the drug registration certificate for emestine fumarate eye drops

Zhitong Finance App News, Zhongsheng Pharmaceutical (002317.SZ) issued an announcement. The company recently received the “Drug Registration Certificate” for imestine fumarate eye drops approved and issued by the State Drug Administration.

This time, emestine fumarate eye drops have been approved for listing in 4 categories of chemical drug registration categories, marking that this product is considered to have passed the chemical generic drug consistency evaluation. It is another pass/ identical pharmaceutical product after the company passed the chemical generic drug consistency evaluation. Following azastine hydrochloride eye drops, praprofen eye drops, diquaphosol eye drops, sodium bromfenac eye drops, moxifloxacin hydrochloride eye drops, brommonidine tartrate eye drops, ciclosporin eye drops (III), compound topicamide eye drops, etc. The company's variety of eye drop products with sexual evaluation has been further enriched in the field of ophthalmology treatment.